Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Refocused Gambro plans dialyser production ramp-up

This article was originally published in Clinica

Executive Summary

Following the announcement that it is to sell its US renal care service arm to DaVita, Sweden's Gambro has revealed plans to open a major new manufacturing site in North America. The decision to step up production capacity for synthetic dialysers reflects growing market demand for these devices over non-synthetic ones, as well as DaVita's commitment to source the majority of its dialysis products from Gambro for at least 10 years.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060463

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel